DekaBank Deutsche Girozentrale increased its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

DekaBank Deutsche Girozentrale increased its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report) by 4.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 147,305 shares of the pharmacy operator’s stock after buying an additional 5,636 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in Walgreens Boots Alliance were worth $1,787,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Atlas Brown Inc. raised its stake in shares of Walgreens Boots Alliance by 1.8% in the first quarter. Atlas Brown Inc. now owns 31,593 shares of the pharmacy operator’s stock worth $685,000 after buying an additional 550 shares during the period. Shilanski & Associates Inc. lifted its position in Walgreens Boots Alliance by 5.3% in the first quarter. Shilanski & Associates Inc. now owns 11,821 shares of the pharmacy operator’s stock worth $256,000 after acquiring an additional 591 shares during the period. First Trust Direct Indexing LP raised its stake in Walgreens Boots Alliance by 1.9% in the first quarter. First Trust Direct Indexing LP now owns 32,085 shares of the pharmacy operator’s stock valued at $696,000 after buying an additional 597 shares in the last quarter. CreativeOne Wealth LLC boosted its holdings in shares of Walgreens Boots Alliance by 7.3% in the fourth quarter. CreativeOne Wealth LLC now owns 10,124 shares of the pharmacy operator’s stock worth $264,000 after purchasing an additional 688 shares during the period. Finally, Buckley Wealth Management LLC boosted its holdings in shares of Walgreens Boots Alliance by 2.1% in the first quarter. Buckley Wealth Management LLC now owns 37,335 shares of the pharmacy operator’s stock valued at $810,000 after purchasing an additional 785 shares during the period. 58.59% of the shares are currently held by hedge funds and other institutional investors.

Analyst upgrades and downgrades

Several equities analysts recently weighed in on the stock. TD Cowen cut their price target on shares of Walgreens Boots Alliance from $22.00 to $16.00 and set a “buy” rating on the stock in a report on Thursday, September 12th. JPMorgan Chase & Co. cut their price target on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a research report on Friday, August 30th. Morgan Stanley cut their price target on Walgreens Boots Alliance from $13.00 to $9.00 and set an “underweight” rating on the stock in a research report on Friday, June 28th. Bank of America cut their price objective on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a report on Wednesday, September 4th. Finally, Royal Bank of Canada cut their price target on Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating for the company in a research report on Tuesday , July 2. Four analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $14.73, according to MarketBeat.

Get the latest stock analysis on WBA

Walgreens Boots Alliance stock fell 0.3%

WBA opened at $8.98 on Friday. The company has a market cap of $7.75 billion, a PE ratio of -1.33, a price-to-earnings-growth ratio of 1.02 and a beta of 0.70. Walgreens Boots Alliance, Inc. it has a twelve month low of $8.46 and a twelve month high of $27.05. The company has a 50-day moving average price of $10.35 and a 200-day moving average price of $14.85. The company has a quick ratio of 0.31, a current ratio of 0.65, and a debt-to-equity ratio of 0.49.

Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report ) last issued its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 EPS for the quarter, missing the consensus estimate of $0.68 by ($0.05). The firm had revenue of $36.40 billion for the quarter, compared to analysts’ expectations of $35.94 billion. Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The company’s revenue for the quarter was up 2.8% compared to the same quarter last year. In the same quarter last year, the company posted earnings of $1.00 per share. Sell-side analysts expect that Walgreens Boots Alliance, Inc. to post 2.86 earnings per share for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 12th. Investors of record on Wednesday, August 21st were given a dividend of $0.25 per share. The ex-dividend date was Wednesday, August 21. This represents a dividend of $1.00 on an annualized basis and a yield of 11.14%. Walgreens Boots Alliance’s payout ratio is currently -14.84%.

About Walgreens Boots Alliance

(Free report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy and retail company in the United States, United Kingdom, Germany and internationally. It operates through three segments: US Retail Pharmacy, International and US Healthcare. The US Retail Pharmacy segment engages in the operation of retail pharmacies, health and wellness services, specialty pharmacy services and home delivery, offering health and wellness, beauty, personal care and supplies and general merchandise.

Featured stories

Get news and reviews for Walgreens Boots Alliance Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Walgreens Boots Alliance and related companies with MarketBeat.com ‘s FREE daily email newsletter.